Heparin calcium 5,000units/0.2ml solution for injection ampoules

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Heparin calcium

থেকে পাওয়া:

Wockhardt UK Ltd

এটিসি কোড:

B01AB01

INN (আন্তর্জাতিক নাম):

Heparin calcium

ডোজ:

25000unit/1ml

ফার্মাসিউটিকাল ফর্ম:

Solution for injection

প্রশাসন রুট:

Subcutaneous; Intravenous

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 02080100; GTIN: 5012727743004

পণ্য বৈশিষ্ট্য

HEPARIN CALCIUM 25,000 I.U./ML SOLUTION FOR
INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION
Summary of Product Characteristics Updated 08-Dec-2015 | Wockhardt UK
Ltd
1. Name of the medicinal product
Monoparin-Ca 25,000 I.U./ml Solution for injection or concentrate for
solution for infusion.
or Heparin calcium 25,000 I.U./ml Solution for injection or
concentrate for solution for infusion.
2. Qualitative and quantitative composition
Heparin calcium 25,000 I.U./ml (5,000 I.U. in 0.2ml)
For excipients see 6.1
3. Pharmaceutical form
Solution for injection or concentrate for solution for infusion
A colourless or straw-coloured liquid, free from turbidity and from
matter that deposits on standing.
4. Clinical particulars
4.1 Therapeutic indications
Prophylaxis of deep vein thrombosis and pulmonary embolism
Treatment of deep vein thrombosis, pulmonary embolism, unstable angina
pectoris and acute peripheral
arterial occlusion.
Prophylaxis of mural thrombosis following myocardial infarction.
In extracorporeal circulation and haemodialysis.
4.2 Posology and method of administration
_Route of administration_
By continuous intravenous infusion in 5% glucose or 0.9% sodium
chloride or by intermittent intravenous
injection, or by subcutaneous injection.
As the effects of heparin are short-lived, administration by
intravenous infusion or subcutaneous injection
is preferable to intermittent intravenous injections.
_Recommended dosage_
Prophylaxis of deep vein thrombosis and pulmonary embolism
_Adults:_
2 hours pre-operatively:
5,000 units subcutaneously
followed by:
5,000 units subcutaneously every 8-12 hours, for 7-10 days or until
the patient
is fully ambulant.
No laboratory monitoring should be necessary during low dose heparin
prophylaxis. If monitoring is
considered desirable, anti-Xa assays should be used as the activated
partial thromboplastin time (APTT)
is not significantly prolonged.
During pregnancy:
5,000 - 10,000 units every 12 hours, subcutaneously, adjusted
according to
APTT or anti-Xa assay.
_Elderly:_
Dosage r